[Treatment of acute ST Elevation myocardial infarction in a regional network ("Drip & Ship Network Rostock")]

Herz
|December 7, 2007
PubMed

Insights

Rapid reperfusion for ST-elevation myocardial infarction (STEMI) is crucial. Network logistics for primary percutaneous coronary intervention (PPCI) in rural areas ensure timely treatment and comparable outcomes to metropolitan centers.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Context:

  • Acute ST-elevation myocardial infarction (STEMI) management requires rapid reperfusion of the infarct-related artery (IRA).
  • Primary percutaneous coronary intervention (PPCI) is the preferred treatment strategy, but regional implementation, especially in rural areas, faces logistical challenges.
  • Effective network logistics and standardized pathways are essential to meet treatment timelines.

Purpose:

  • To evaluate the feasibility and outcomes of a Drip&Ship network for PPCI in STEMI patients, comparing transferred patients with directly admitted patients.
  • To assess the impact of network logistics on treatment delays, procedural success, and long-term prognosis.

Summary:

  • A 5-year analysis of 1,022 STEMI patients within the Drip&Ship network Rostock showed successful PPCI in over 94% of transferred and directly admitted patients.
  • Both groups achieved successful IRA reperfusion (96%) without thrombolytic therapy, demonstrating comparable 12-month infarct size, mortality, and left ventricular ejection fraction.
  • The implemented 24/7 network logistics, including direct physician-to-physician communication and immediate cath lab access, facilitated timely and effective PPCI.

Impact:

  • Transportation of STEMI patients within an established PCI network does not result in a prognostic disadvantage.
  • Efficient network logistics ensure safety and comparable outcomes for STEMI patients treated with PPCI, regardless of their initial point of care.
  • This model supports the successful regional implementation of PPCI, improving access to time-sensitive cardiac care in underserved areas.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...